ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 80

Prediction of Future Development of Rheumatoid Arthritis in Patients with Seropositive Arthralgia

Candice Low1, Richard Conway2, Francis Young3, Eamonn S. Molloy4, Anne Barbara Mongey4, Anthony G. Wilson5, Ursula Fearon6 and Douglas J. Veale1, 1Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 2CARD Newman Research Fellow, University College Dublin, Dublin, Ireland, 3Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin 4, Ireland, 4Saint Vincent's University Hospital, Dublin 4, Ireland, 5UCD School of Medicine and Medical Science, Conway Institute, University College Dublin, Dublin, Ireland, 6Molecular Rheumatology, School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Early Rheumatoid Arthritis and arthroscopy

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Sunday, October 21, 2018

Session Title: Rheumatoid Arthritis – Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Arthralgia in patients who are seropositive for rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) is a precursor to rheumatoid arthritis (RA) in some but not all patients. The factors which influence progression and outcomes in these patients remain to be fully defined. The aim of this study was to evaluate outcome and prognostic factors in a consecutive cohort of patients with seropositive arthralgia undergoing arthroscopy.

Methods:

We performed a prospective study of consecutive patients seropositive for RF and/or ACPA, with arthralgia, presenting to our outpatient clinic. Demographic and clinical measures were collected and synovial biopsy was performed by needle arthroscopy to score macroscopic and microscopic changes. The degree of synovitis and vascularity were recorded on a 0–100-mm visual analog scale, and chondropathy on a semi-quantitative scale from 0-3. Patients were then followed up at 3 monthly intervals and the time of diagnosis recorded. Mann-Whitney U test was used to compare groups. Spearman’s Rank Correlation Coefficient was used to assess for associations between biometrics and demographic and clinical markers. GraphPad Prism Version 7 and IBM SPSS Statistics Version 24 were used for data analysis.

Results:

33 patients were recruited. Mean (SD) age was 54 (12) years. 22 (67%) were female. 27 (82%) were positive for RF and 30 (91%) for ACPA with 24 (73%) dual positive. Mean (SD) follow-up was 29 (10) months. Baseline characteristics are shown in Table 1. Final diagnosis was RA in 24 (73%), psoriatic arthritis in 2 (6%), connective tissue disease in 1 (3%), calcium pyrophosphate arthritis in 1 (3%), and remained seropositive arthralgia in 5 (15%). Baseline CRP was significantly higher in patients who developed rheumatoid arthritis than those who remained seropositive arthralgia, mean (SD) 9.63 (16.63) vs 1.40 (0.55) mg/dL (p=0.005). CRP was elevated in 9/24 RA patients (range 1-64 mg/dL), and 0/5 who remained seropositive arthralgia (range 1-2 mg/dL). Macroscopic synovitis and vascularity were both significantly higher in those who developed RA than in those who remained arthralgia only, mean (SD) 60 (25) vs 28 (13) mm (p=0.009) and mean (SD) 56 (26) vs 26 (13) mm (p=0.012) respectively. Baseline DAS28-CRP, tender joint count, swollen joint count, and patient global assessment were not different between the groups. Baseline synovial cell immunophenotyping did not predict final diagnosis.

Conclusion:

The majority of seropositive arthralgia patients developed RA. Elevated baseline CRP and macroscopic synovitis and vascularity scores at arthroscopy predict the future development of RA.

Table 1: Baseline Characteristics of 33 Patients with Seropositive Arthralgia

Age, years

54 (12)

Sex, female, n (%)

22 (67%)

Tender Joint Count

3 (6)

Swollen Joint Count

0 (0)

Patient Global Assessment (mm)

47 (28)

DAS28-CRP

3.42 (1.34)

Arthroscopic synovitis (mm)

56 (26)

Arthroscopic vascularity (mm)

53 (26)

Data expressed as mean (SD) unless otherwise specified.


Disclosure: C. Low, None; R. Conway, None; F. Young, None; E. S. Molloy, None; A. B. Mongey, None; A. G. Wilson, None; U. Fearon, None; D. J. Veale, None.

To cite this abstract in AMA style:

Low C, Conway R, Young F, Molloy ES, Mongey AB, Wilson AG, Fearon U, Veale DJ. Prediction of Future Development of Rheumatoid Arthritis in Patients with Seropositive Arthralgia [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 10). https://acrabstracts.org/abstract/prediction-of-future-development-of-rheumatoid-arthritis-in-patients-with-seropositive-arthralgia/. Accessed December 10, 2019.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prediction-of-future-development-of-rheumatoid-arthritis-in-patients-with-seropositive-arthralgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.